Original paper

A Novel hERG 1a/1b Stable Cell Line for Drug Screening and Research Applications

Volume: 114, Issue: 3, Pages: 292a - 292a
Published: Feb 1, 2018
Abstract
New therapies for a wide range of diseases are counter-screened against hERG potassium channels to reduce the risk of acquired long QT syndrome and life-threatening arrhythmias. Despite evidence that cardiac IKr is produced by heteromeric hERG 1a/1b channels (Jones et al., 2004, Sale et al., 2008, Jones et al., 2014), rather than the homomeric hERG 1a typically utilized in screening, implementation of the more native-like channel has been...
Paper Details
Title
A Novel hERG 1a/1b Stable Cell Line for Drug Screening and Research Applications
Published Date
Feb 1, 2018
Volume
114
Issue
3
Pages
292a - 292a
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.